Since STC2 is associated with ER signaling pathway as well as previous studies identifying STC2 as a potential predictive marker for survival [34], we further analyzed its impact on RFS in breast cancer patients stratified by ER status. The gene discussed is STC2; the disease is breast carcinoma.